WHO calls to action on blindness

Article

The global initiative Vision2020: Right to Sight has received a major boost following the endorsement of the WHO Action Plan for the Prevention of Avoidable Blindness and Visual Impairment by the 62nd World Health Assembly, the WHO governing body.

The global initiative Vision2020: Right to Sight has received a major boost following the endorsement of the WHO Action Plan for the Prevention of Avoidable Blindness and Visual Impairment by the 62nd World Health Assembly, the WHO governing body.

WHO team leader for Prevention of Blindness & Deafness, Dr. Ivo Kocur said: “Adoption of the Action Plan by the WHA is a major accomplishment and will provide additional unprecedented support to VISION 2020 and our joint efforts to improve eye health internationally.”>

The plan aims to expand the efforts made by member states, WHO and international partners in Vision 2020 to help prevent blindness and visual impairment by the development of comprehensive eye health programmes at national & sub-national levels. It sets out current experience, draws on the recognised achievements and deals with gaps in implementing activities over the past decades.

OTEurope is fully supportive of the work of Vision2020 and is looking forward to highlighting more of its work over the coming months.

The current Action Plan can be downloaded from the WHO website here and full coverage of the 62nd World Health Assembly is available online

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.